<table> 
<tbody>
<tr><th>Rank</th><th>Pathway</th><th>q-value</th></tr>
<tr><td>1</td><td>Cyclin D associated events in G1</td><td>4.978015752048342e-07</td></tr>
<tr><td>2</td><td>G1 Phase</td><td>4.978015752048342e-07</td></tr>
<tr><td>3</td><td>Diseases of Cellular Senescence</td><td>7.901997464172283e-07</td></tr>
<tr><td>4</td><td>Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6</td><td>7.901997464172283e-07</td></tr>
<tr><td>5</td><td>Evasion of Oncogene Induced Senescence Due to p16INK4A Defects</td><td>7.901997464172283e-07</td></tr>
<tr><td>6</td><td>Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6</td><td>7.901997464172283e-07</td></tr>
<tr><td>7</td><td>Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects</td><td>7.901997464172283e-07</td></tr>
<tr><td>8</td><td>Transcriptional Regulation by MECP2</td><td>9.18944918155518e-07</td></tr>
<tr><td>9</td><td>SLC-mediated transmembrane transport</td><td>5.442151726984185e-06</td></tr>
<tr><td>10</td><td>Oncogene Induced Senescence</td><td>5.666841212008241e-06</td></tr>
<tr><td>11</td><td>Transport of bile salts and organic acids, metal ions and amine compounds</td><td>9.134186015404346e-06</td></tr>
<tr><td>12</td><td>SUMOylation of DNA replication proteins</td><td>1.1614082032674017e-05</td></tr>
<tr><td>13</td><td>Metabolism of nucleotides</td><td>1.324425957386905e-05</td></tr>
<tr><td>14</td><td>RHO GTPases Activate Rhotekin and Rhophilins</td><td>1.3245638726702523e-05</td></tr>
<tr><td>15</td><td>G2 Phase</td><td>1.4301513081475966e-05</td></tr>
<tr><td>16</td><td>SLC transporter disorders</td><td>2.1266208618469568e-05</td></tr>
<tr><td>17</td><td>mRNA Splicing - Minor Pathway</td><td>2.1266208618469568e-05</td></tr>
<tr><td>18</td><td>Serine biosynthesis</td><td>2.5563744471118988e-05</td></tr>
<tr><td>19</td><td>SUMO E3 ligases SUMOylate target proteins</td><td>2.6544288396166688e-05</td></tr>
<tr><td>20</td><td>Sphingolipid metabolism</td><td>2.7757746099101316e-05</td></tr>
<tr><td>21</td><td>Synthesis of PC</td><td>2.7757746099101316e-05</td></tr>
<tr><td>22</td><td>RHO GTPases Activate Formins</td><td>2.9237893280068816e-05</td></tr>
<tr><td>23</td><td>Glycosphingolipid metabolism</td><td>3.363439907717238e-05</td></tr>
<tr><td>24</td><td>Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA</td><td>3.463063521939002e-05</td></tr>
<tr><td>25</td><td>RHO GTPase Effectors</td><td>3.463063521939002e-05</td></tr>
<tr><td>26</td><td>Regulation of TP53 Activity through Phosphorylation</td><td>3.463063521939002e-05</td></tr>
<tr><td>27</td><td>Purine catabolism</td><td>3.463063521939002e-05</td></tr>
<tr><td>28</td><td>Transport of Mature mRNA Derived from an Intronless Transcript</td><td>3.463063521939002e-05</td></tr>
<tr><td>29</td><td>Vpr-mediated nuclear import of PICs</td><td>3.463063521939002e-05</td></tr>
<tr><td>30</td><td>Miscellaneous transport and binding events</td><td>3.463063521939002e-05</td></tr>
<tr><td>31</td><td>Nucleobase biosynthesis</td><td>3.5193070605199625e-05</td></tr>
<tr><td>32</td><td>SUMOylation</td><td>3.679968946893385e-05</td></tr>
<tr><td>33</td><td>Transport of the SLBP independent Mature mRNA</td><td>3.679968946893385e-05</td></tr>
<tr><td>34</td><td>Cell Cycle, Mitotic</td><td>3.679968946893385e-05</td></tr>
<tr><td>35</td><td>SUMOylation of DNA damage response and repair proteins</td><td>3.679968946893385e-05</td></tr>
<tr><td>36</td><td>Cell Cycle</td><td>3.679968946893385e-05</td></tr>
<tr><td>37</td><td>Amino acid transport across the plasma membrane</td><td>3.728663969648608e-05</td></tr>
<tr><td>38</td><td>G1/S-Specific Transcription</td><td>3.994347548389903e-05</td></tr>
<tr><td>39</td><td>Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1</td><td>4.5577300510654685e-05</td></tr>
<tr><td>40</td><td>RNA Polymerase III Transcription Termination</td><td>4.7367676724153774e-05</td></tr>
<tr><td>41</td><td>TFAP2 (AP-2) family regulates transcription of growth factors and their receptors</td><td>4.7367676724153774e-05</td></tr>
<tr><td>42</td><td>Ubiquinol biosynthesis</td><td>4.7367676724153774e-05</td></tr>
<tr><td>43</td><td>Cell Cycle Checkpoints</td><td>4.825257789331242e-05</td></tr>
<tr><td>44</td><td>Purine ribonucleoside monophosphate biosynthesis</td><td>4.825257789331242e-05</td></tr>
<tr><td>45</td><td>Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function</td><td>4.825257789331242e-05</td></tr>
<tr><td>46</td><td>Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)</td><td>4.825257789331242e-05</td></tr>
<tr><td>47</td><td>Nuclear Envelope Breakdown</td><td>4.825257789331242e-05</td></tr>
<tr><td>48</td><td>Host Interactions with Influenza Factors</td><td>4.825257789331242e-05</td></tr>
<tr><td>49</td><td>Mitotic G2-G2/M phases</td><td>4.825257789331242e-05</td></tr>
<tr><td>50</td><td>Diseases of Programmed Cell Death</td><td>4.825257789331242e-05</td></tr>
</tbody> 
</table>